 | ZLF | Name: | S-(1-FLUORO-3,5-DIMETHYLBENZENE)-CYSTEINE | Formula: | C11 H14 F N O2 S | SMILES: | Cc1cc(F)cc(CSC[CH](N)C(O)=O)c1 | InChi: | InChI=1S/C11H14FNO2S/c1-7-2-8(4-9(12)3-7)5-16-6-10(13)11(14)15/h2-4,10H,5-6,13H2,1H3,(H,14,15)/t10-/m0/s1 | Synonyms: | 2-azanyl-3-[(3-fluoranyl-5-methyl-phenyl)methylsulfanyl]propanoic acid | Definition date: | 2024-01-22 | Last modified: | 2024-09-27 | Release date: | 2024-04-24 | Identifier: | 2-azanyl-3-[(3-fluoranyl-5-methyl-phenyl)methylsulfanyl]propanoic acid |
|
 | FIF | Name: | 2,6-anhydro-5-deoxy-5-fluoro-L-idonic acid | Formula: | C6 H9 F O5 | SMILES: | FC1C(O)C(O)C(OC1)C(=O)O | InChi: | InChI=1S/C6H9FO5/c7-2-1-12-5(6(10)11)4(9)3(2)8/h2-5,8-9H,1H2,(H,10,11)/t2-,3+,4-,5+/m0/s1 | Synonyms: | 2-deoxy-2-fluoro-alpha-L-idopyranuronosyl fluoride, bound form | Definition date: | 2013-05-07 | Last modified: | 2024-09-27 | Release date: | 2013-09-18 | Identifier: | 2,6-anhydro-5-deoxy-5-fluoro-L-idonic acid |
|
 | NMC | Name: | N-CYCLOPROPYLMETHYL GLYCINE | Formula: | C6 H11 N O2 | SMILES: | O=C(O)CNCC1CC1 | InChi: | InChI=1S/C6H11NO2/c8-6(9)4-7-3-5-1-2-5/h5,7H,1-4H2,(H,8,9) | Definition date: | 1999-07-08 | Last modified: | 2024-09-27 | Identifier: | N-(cyclopropylmethyl)glycine |
|
 | FIK | Name: | (1S,2S)-2-[(N-{[(2-acetyl-2-azaspiro[3.3]heptan-6-yl)oxy]carbonyl}-L-leucyl)amino]-1-hydroxy-3-[(3S)-2-oxopyrrolidin-3-yl]propane-1-sulfonic acid | Formula: | C24 H40 N4 O9 S | SMILES: | O=C(C(C)C)N1CC2(CC(C2)OC(=O)NC(CC(C)C)C(=O)NC(CC2CCNC2=O)C(O)S(=O)(=O)O)C1 | InChi: | InChI=1S/C24H40N4O9S/c1-13(2)7-17(20(30)26-18(22(32)38(34,35)36)8-15-5-6-25-19(15)29)27-23(33)37-16-9-24(10-16)11-28(12-24)21(31)14(3)4/h13-18,22,32H,5-12H2,1-4H3,(H,25,29)(H,26,30)(H,27,33)(H,34,35,36)/t15-,17-,18-,22-/m0/s1 | Definition date: | 2021-12-15 | Last modified: | 2024-09-27 | Release date: | 2021-12-22 | Identifier: | (1S,2S)-1-hydroxy-2-{[N-({[2-(2-methylpropanoyl)-2-azaspiro[3.3]heptan-6-yl]oxy}carbonyl)-L-leucyl]amino}-3-[(3S)-2-oxopyrrolidin-3-yl]propane-1-sulfonic acid |
|
 | NME | Name: | METHYLAMINE | Formula: | C H5 N | SMILES: | NC | InChi: | InChI=1S/CH5N/c1-2/h2H2,1H3 | Definition date: | 1999-07-08 | Last modified: | 2024-09-27 | Identifier: | methanamine |
|
 | FIO | Name: | N~5~-[(1E)-2-fluoroethanimidoyl]-L-ornithine | Formula: | C7 H14 F N3 O2 | SMILES: | O=C(O)C(N)CCCNC(=[N@H])CF | InChi: | InChI=1S/C7H14FN3O2/c8-4-6(10)11-3-1-2-5(9)7(12)13/h5H,1-4,9H2,(H2,10,11)(H,12,13)/t5-/m0/s1 | Definition date: | 2012-02-17 | Last modified: | 2024-09-27 | Identifier: | N~5~-[(1E)-2-fluoroethanimidoyl]-L-ornithine |
|
 | YXY | Name: | 4,4-difluorocyclohexane-1-carboxamide | Formula: | C7 H11 F2 N O | SMILES: | FC1(F)CCC(CC1)C(N)=O | InChi: | InChI=1S/C7H11F2NO/c8-7(9)3-1-5(2-4-7)6(10)11/h5H,1-4H2,(H2,10,11) | Definition date: | 2023-06-22 | Last modified: | 2024-09-27 | Release date: | 2023-07-12 | Identifier: | 4,4-difluorocyclohexane-1-carboxamide |
|
 | NMI | Name: | 3-(1-methyl-1H-indol-3-yl)propanoic acid | Formula: | C12 H13 N O2 | SMILES: | O=C(O)CCc2c1ccccc1n(c2)C | InChi: | InChI=1S/C12H13NO2/c1-13-8-9(6-7-12(14)15)10-4-2-3-5-11(10)13/h2-5,8H,6-7H2,1H3,(H,14,15) | Definition date: | 2014-04-07 | Last modified: | 2024-09-27 | Release date: | 2014-06-18 | Identifier: | 3-(1-methyl-1H-indol-3-yl)propanoic acid |
|
 | NMK | Name: | N-methyl Lysine | Formula: | C7 H17 N2 O2 | SMILES: | CN[CH](CCCC[NH3+])C(O)=O | InChi: | InChI=1S/C7H16N2O2/c1-9-6(7(10)11)4-2-3-5-8/h6,9H,2-5,8H2,1H3,(H,10,11)/p+1/t6-/m0/s1 | Definition date: | 2018-10-10 | Last modified: | 2024-09-27 | Release date: | 2019-01-16 | Identifier: | [(5~{S})-5-(methylamino)-6-oxidanyl-6-oxidanylidene-hexyl]azanium |
|
 | NML | Name: | N-METHYLACETAMIDE | Formula: | C3 H7 N O | SMILES: | O=C(NC)C | InChi: | InChI=1S/C3H7NO/c1-3(5)4-2/h1-2H3,(H,4,5) | Definition date: | 2006-10-27 | Last modified: | 2024-09-27 | Identifier: | N-methylacetamide |
|
 | YY3 | Name: | N-(2-{[2-(dimethylamino)ethyl](methyl)amino}-4-methoxy-5-{[4-(1-methyl-1H-indol-3-yl)pyrimidin-2-yl]amino}phenyl)prop-2-enamide | Formula: | C28 H33 N7 O2 | SMILES: | CN(CCN(c1cc(c(cc1NC(C=C)=O)Nc2nc(ccn2)c3cn(c4c3cccc4)C)OC)C)C | InChi: | InChI=1S/C28H33N7O2/c1-7-27(36)30-22-16-23(26(37-6)17-25(22)34(4)15-14-33(2)3)32-28-29-13-12-21(31-28)20-18-35(5)24-11-9-8-10-19(20)24/h7-13,16-18H,1,14-15H2,2-6H3,(H,30,36)(H,29,31,32) | Synonyms: | Osimertinib | Definition date: | 2015-04-14 | Last modified: | 2024-09-27 | Release date: | 2015-11-11 | Identifier: | N-(2-{[2-(dimethylamino)ethyl](methyl)amino}-4-methoxy-5-{[4-(1-methyl-1H-indol-3-yl)pyrimidin-2-yl]amino}phenyl)prop-2-enamide |
|
 | NMM | Name: | (2S)-2-amino-5-[(N-methylcarbamimidoyl)amino]pentanoic acid | Formula: | C7 H16 N4 O2 | SMILES: | O=C(O)C(N)CCCNC(=[N@H])NC | InChi: | InChI=1S/C7H16N4O2/c1-10-7(9)11-4-2-3-5(8)6(12)13/h5H,2-4,8H2,1H3,(H,12,13)(H3,9,10,11)/t5-/m0/s1 | Synonyms: | L-NMMA | Definition date: | 2005-12-28 | Last modified: | 2024-09-27 | Identifier: | N~5~-(N-methylcarbamimidoyl)-L-ornithine |
|
 | FIW | Name: | (1R,2S)-1-hydroxy-2-{[N-({[2-(2-methylpropanoyl)-2-azaspiro[3.3]heptan-6-yl]oxy}carbonyl)-L-leucyl]amino}-3-[(3S)-2-oxopyrrolidin-3-yl]propane-1-sulfonic acid | Formula: | C24 H40 N4 O9 S | SMILES: | O=C(C(C)C)N1CC2(CC(C2)OC(=O)NC(CC(C)C)C(=O)NC(CC2CCNC2=O)C(O)S(=O)(=O)O)C1 | InChi: | InChI=1S/C24H40N4O9S/c1-13(2)7-17(20(30)26-18(22(32)38(34,35)36)8-15-5-6-25-19(15)29)27-23(33)37-16-9-24(10-16)11-28(12-24)21(31)14(3)4/h13-18,22,32H,5-12H2,1-4H3,(H,25,29)(H,26,30)(H,27,33)(H,34,35,36)/t15-,17-,18-,22+/m0/s1 | Definition date: | 2021-12-15 | Last modified: | 2024-09-27 | Release date: | 2021-12-22 | Identifier: | (1R,2S)-1-hydroxy-2-{[N-({[2-(2-methylpropanoyl)-2-azaspiro[3.3]heptan-6-yl]oxy}carbonyl)-L-leucyl]amino}-3-[(3S)-2-oxopyrrolidin-3-yl]propane-1-sulfonic acid |
|
 | YK3 | Name: | tert-butyl [(6S,10P)-4-{4-[(ethanesulfonyl)amino]phenyl}-2,3,9-trimethyl-6H-thieno[3,2-f][1,2,4]triazolo[4,3-a][1,4]diazepin-6-yl]acetate | Formula: | C25 H31 N5 O4 S2 | SMILES: | CCS(=O)(=O)Nc1ccc(cc1)C1=NC(CC(=O)OC(C)(C)C)c2nnc(C)n2c2sc(C)c(C)c21 | InChi: | InChI=1S/C25H31N5O4S2/c1-8-36(32,33)29-18-11-9-17(10-12-18)22-21-14(2)15(3)35-24(21)30-16(4)27-28-23(30)19(26-22)13-20(31)34-25(5,6)7/h9-12,19,29H,8,13H2,1-7H3/t19-/m0/s1 | Definition date: | 2023-02-09 | Last modified: | 2024-09-27 | Release date: | 2023-03-08 | Identifier: | tert-butyl [(6S,10P)-4-{4-[(ethanesulfonyl)amino]phenyl}-2,3,9-trimethyl-6H-thieno[3,2-f][1,2,4]triazolo[4,3-a][1,4]diazepin-6-yl]acetate |
|
 | NMP | Name: | 2-[2-(2-CYCLOHEXYL-2-GUANIDINO-ACETYLAMINO)-ACETYLAMINO]-N-(3-MERCAPTO-PROPYL)-PROPIONAMIDE | Formula: | C17 H32 N6 O3 S | SMILES: | O=C(NCCCS)C(NC(=O)CNC(=O)C(NC(=[N@H])N)C1CCCCC1)C | InChi: | InChI=1S/C17H32N6O3S/c1-11(15(25)20-8-5-9-27)22-13(24)10-21-16(26)14(23-17(18)19)12-6-3-2-4-7-12/h11-12,14,27H,2-10H2,1H3,(H,20,25)(H,21,26)(H,22,24)(H4,18,19,23)/t11-,14+/m0/s1 | Definition date: | 2002-07-09 | Last modified: | 2024-09-27 | Identifier: | N-[(2R)-2-carbamimidamido-2-cyclohexylacetyl]glycyl-N-(3-sulfanylpropyl)-L-alaninamide |
|
 | YYA | Name: | 2,4,5-trideoxy-2-(methylamino)-4-[(2Z)-penta-2,4-dien-1-yl]-L-xylonic acid | Formula: | C11 H19 N O3 | SMILES: | O=C(O)C(NC)C(O)C(CC=C/C=C)C | InChi: | InChI=1S/C11H19NO3/c1-4-5-6-7-8(2)10(13)9(12-3)11(14)15/h4-6,8-10,12-13H,1,7H2,2-3H3,(H,14,15)/b6-5-/t8-,9+,10-/m1/s1 | Definition date: | 2010-11-19 | Last modified: | 2024-09-27 | Identifier: | 2,4,5-trideoxy-2-(methylamino)-4-[(2Z)-penta-2,4-dien-1-yl]-L-xylonic acid |
|
 | ZM5 | Name: | (2R)-2-(tridecanoyloxy)propyl hexadecanoate | Formula: | C32 H62 O5 | SMILES: | CCCCCCCCCCCCCCCC(=O)OC[CH](CO)OC(=O)CCCCCCCCCCCC | InChi: | InChI=1S/C32H62O5/c1-3-5-7-9-11-13-15-16-17-19-20-22-24-26-31(34)36-29-30(28-33)37-32(35)27-25-23-21-18-14-12-10-8-6-4-2/h30,33H,3-29H2,1-2H3/t30-/m1/s1 | Synonyms: | (3-oxidanyl-2-tridecanoyloxy-propyl) hexadecanoate | Definition date: | 2024-01-22 | Last modified: | 2024-09-27 | Release date: | 2024-04-17 | Identifier: | (3-oxidanyl-2-tridecanoyloxy-propyl) hexadecanoate |
|
 | YKA | Name: | (1R,2S)-2-((S)-2-((((2-(4,4-difluorocyclohexyl)propan-2-yl)oxy)carbonyl)amino)-4-methylpentanamido)-1-hydroxy-3-((R)-2-oxo-3,4-dihydro-2H-pyrrol-3-yl)propane-1-sulfonic acid | Formula: | C23 H37 F2 N3 O8 S | SMILES: | O=C1N=CCC1CC(NC(=O)C(CC(C)C)NC(=O)OC(C)(C)C1CCC(F)(F)CC1)C(O)S(=O)(=O)O | InChi: | InChI=1S/C23H37F2N3O8S/c1-13(2)11-16(28-21(32)36-22(3,4)15-5-8-23(24,25)9-6-15)19(30)27-17(20(31)37(33,34)35)12-14-7-10-26-18(14)29/h10,13-17,20,31H,5-9,11-12H2,1-4H3,(H,27,30)(H,28,32)(H,33,34,35)/t14-,16-,17-,20+/m0/s1 | Definition date: | 2021-03-11 | Last modified: | 2024-09-27 | Release date: | 2021-03-24 | Identifier: | (1R,2S)-2-{[N-({[2-(4,4-difluorocyclohexyl)propan-2-yl]oxy}carbonyl)-L-leucyl]amino}-1-hydroxy-3-[(3R)-2-oxo-3,4-dihydro-2H-pyrrol-3-yl]propane-1-sulfonic acid |
|
 | A1D5E | Name: | (2~{S},4~{R})-4-(2-azanylethylcarbamoyloxy)pyrrolidine-2-carboxylic acid | Formula: | C8 H15 N3 O4 | SMILES: | NCCNC(=O)O[CH]1CN[CH](C1)C(O)=O | InChi: | InChI=1S/C8H15N3O4/c9-1-2-10-8(14)15-5-3-6(7(12)13)11-4-5/h5-6,11H,1-4,9H2,(H,10,14)(H,12,13)/t5-,6+/m1/s1 | Synonyms: | 4-((((2-AMINOETHYL)AMINO)CARBONYL)OXY)-L-PROLINE, (4R)- | Definition date: | 2024-01-04 | Last modified: | 2024-09-27 | Release date: | 2024-07-03 | Identifier: | (2~{S},4~{R})-4-(2-azanylethylcarbamoyloxy)pyrrolidine-2-carboxylic acid |
|
 | Y71 | Name: | (1S,2S)-2-((S)-2-(((((1S,2S,4S)-bicyclo[2.2.1]hept-5-en-2-yl)methoxy)carbonyl)amino)-4-methylpentanamido)-1-hydroxy-3-((S)-2-oxopyrrolidin-3-yl)propane-1-sulfonic acid | Formula: | C22 H35 N3 O8 S | SMILES: | CC(C)C[CH](NC(=O)OC[CH]1C[CH]2C[CH]1C=C2)C(=O)N[CH](C[CH]3CCNC3=O)[CH](O)[S](O)(=O)=O | InChi: | InChI=1S/C22H35N3O8S/c1-12(2)7-17(25-22(29)33-11-16-9-13-3-4-14(16)8-13)20(27)24-18(21(28)34(30,31)32)10-15-5-6-23-19(15)26/h3-4,12-18,21,28H,5-11H2,1-2H3,(H,23,26)(H,24,27)(H,25,29)(H,30,31,32)/t13-,14+,15-,16+,17-,18-,21-/m0/s1 | Definition date: | 2021-02-08 | Last modified: | 2024-09-27 | Release date: | 2021-02-17 | Identifier: | (2~{S})-2-[[(2~{S})-2-[[(1~{S},2~{S},4~{S})-2-bicyclo[2.2.1]hept-5-enyl]methoxycarbonylamino]-4-methyl-pentanoyl]amino]-1-oxidanyl-3-[(3~{S})-2-oxidanylidenepyrrolidin-3-yl]propane-1-sulfonic acid |
|
 | A1D5P | Name: | (2~{R},3~{S})-2-azanyl-3-(4-hydroxyphenyl)-3-oxidanyl-propanoic acid | Formula: | C9 H11 N O4 | SMILES: | N[CH]([CH](O)c1ccc(O)cc1)C(O)=O | InChi: | InChI=1S/C9H11NO4/c10-7(9(13)14)8(12)5-1-3-6(11)4-2-5/h1-4,7-8,11-12H,10H2,(H,13,14)/t7-,8+/m1/s1 | Synonyms: | (betaS)-beta-hydroxy-D-tyrosine | Definition date: | 2024-01-26 | Last modified: | 2024-09-27 | Release date: | 2024-06-12 | Identifier: | (2~{R},3~{S})-2-azanyl-3-(4-hydroxyphenyl)-3-oxidanyl-propanoic acid |
|
 | YKD | Name: | (1S,2S)-2-((S)-2-((((2-(4,4-difluorocyclohexyl)propan-2-yl)oxy)carbonyl)amino)-4-methylpentanamido)-1-hydroxy-3-((R)-2-oxo-3,4-dihydro-2H-pyrrol-3-yl)propane-1-sulfonic acid | Formula: | C23 H37 F2 N3 O8 S | SMILES: | O=C1N=CCC1CC(NC(=O)C(CC(C)C)NC(=O)OC(C)(C)C1CCC(F)(F)CC1)C(O)S(=O)(=O)O | InChi: | InChI=1S/C23H37F2N3O8S/c1-13(2)11-16(28-21(32)36-22(3,4)15-5-8-23(24,25)9-6-15)19(30)27-17(20(31)37(33,34)35)12-14-7-10-26-18(14)29/h10,13-17,20,31H,5-9,11-12H2,1-4H3,(H,27,30)(H,28,32)(H,33,34,35)/t14-,16-,17-,20-/m0/s1 | Definition date: | 2021-03-11 | Last modified: | 2024-09-27 | Release date: | 2021-03-24 | Identifier: | (1S,2S)-2-{[N-({[2-(4,4-difluorocyclohexyl)propan-2-yl]oxy}carbonyl)-L-leucyl]amino}-1-hydroxy-3-[(3R)-2-oxo-3,4-dihydro-2H-pyrrol-3-yl]propane-1-sulfonic acid |
|
 | ZMD | Name: | (3S)-2,1-benzoxaborole-1,3(3H)-diol | Formula: | C7 H7 B O3 | SMILES: | OB1OC(O)c2ccccc12 | InChi: | InChI=1S/C7H7BO3/c9-7-5-3-1-2-4-6(5)8(10)11-7/h1-4,7,9-10H/t7-/m0/s1 | Definition date: | 2021-05-07 | Last modified: | 2024-09-27 | Release date: | 2021-08-11 | Identifier: | (3S)-2,1-benzoxaborole-1,3(3H)-diol |
|
 | YKF | Name: | methyl 2-formyl-2-[3-methyl-4-(3-phenoxybenzamido)phenyl]hydrazine-1-carboxylate | Formula: | C23 H21 N3 O5 | SMILES: | O=C(OC)NN(C=O)c1ccc(NC(=O)c2cc(Oc3ccccc3)ccc2)c(C)c1 | InChi: | InChI=1S/C23H21N3O5/c1-16-13-18(26(15-27)25-23(29)30-2)11-12-21(16)24-22(28)17-7-6-10-20(14-17)31-19-8-4-3-5-9-19/h3-15H,1-2H3,(H,24,28)(H,25,29) | Definition date: | 2023-02-09 | Last modified: | 2024-09-27 | Release date: | 2024-02-21 | Identifier: | methyl 2-formyl-2-[3-methyl-4-(3-phenoxybenzamido)phenyl]hydrazine-1-carboxylate |
|
 | FJC | Name: | ~{N}-[(2~{S})-3-(3-fluorophenyl)-1-oxidanylidene-1-[[(2~{S})-1-oxidanylidene-3-[(3~{S})-2-oxidanylidenepyrrolidin-3-yl]propan-2-yl]amino]propan-2-yl]-1~{H}-indole-2-carboxamide | Formula: | C25 H25 F N4 O4 | SMILES: | Fc1cccc(C[CH](NC(=O)c2[nH]c3ccccc3c2)C(=O)N[CH](C[CH]4CCNC4=O)C=O)c1 | InChi: | InChI=1S/C25H25FN4O4/c26-18-6-3-4-15(10-18)11-21(24(33)28-19(14-31)12-17-8-9-27-23(17)32)30-25(34)22-13-16-5-1-2-7-20(16)29-22/h1-7,10,13-14,17,19,21,29H,8-9,11-12H2,(H,27,32)(H,28,33)(H,30,34)/t17-,19-,21-/m0/s1 | Definition date: | 2020-05-14 | Last modified: | 2024-09-27 | Release date: | 2020-05-27 | Identifier: | ~{N}-[(2~{S})-3-(3-fluorophenyl)-1-oxidanylidene-1-[[(2~{S})-1-oxidanylidene-3-[(3~{S})-2-oxidanylidenepyrrolidin-3-yl]propan-2-yl]amino]propan-2-yl]-1~{H}-indole-2-carboxamide |
|